MedPath

Examination of the effectiveness against retinal vascular occlusion treated with retinal endovascular surgery using tissue plasminogen activator.

Not Applicable
Conditions
retinal vein occlusion retinal artery occlusion
Registration Number
JPRN-UMIN000024593
Lead Sponsor
Kyoto Prefectual Univercity of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

We take patient's past medical history. We exclude a patient with cerebrovascular disorders and patient with a history of cerebral infarction and blood disease. And the case is judged to be at high risk to use t-PA for patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative week 1 : visual acuity, postoperative complication , Optical Coherence Tomography (OCT) Postoperative week 4 : visual acuity, postoperative complication , OCT Postoperative week 12 : visual acuity, postoperative complication , OCT Postoperative week 24 : visual acuity, postoperative complication , OCT , fluorescein fundus angiography (FAG)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath